Cellebrite Reports Robust Q1 2025 Financial Performance

Cellebrite DI ( (CLBT) ) just unveiled an update.

Cellebrite DI Ltd. announced strong financial results for the first quarter of 2025, with revenue reaching $107.5 million, marking a 20% increase year-over-year. The company reported a 23% growth in Annual Recurring Revenue (ARR) and a 34% rise in adjusted EBITDA, reflecting its strategic focus on subscription services and operational efficiency. The introduction of the Cellebrite Cloud and AI-powered innovations has enhanced their digital investigation platform, contributing to improved customer workflows and productivity. Additionally, Cellebrite hosted its first user conference, highlighting its commitment to innovation and community engagement within the digital investigation industry.

The most recent analyst rating on (CLBT) stock is a Buy with a $14.00 price target. To see the full list of analyst forecasts on Cellebrite DI stock, see the CLBT Stock Forecast page.

Spark’s Take on CLBT Stock

According to Spark, TipRanks’ AI Analyst, CLBT is a Neutral.

Cellebrite DI’s overall score reflects strong revenue growth and operational improvements, offset by challenges in profitability and valuation concerns due to negative net income. The positive earnings call and technical indicators suggest potential upside, while stable cash flow generation supports future operational stability. The absence of dividends and negative P/E ratio are notable valuation concerns.

To see Spark’s full report on CLBT stock, click here.

More about Cellebrite DI

Cellebrite DI Ltd. is a global leader in digital investigative solutions, catering to both public and private sectors. The company focuses on providing advanced tools for digital investigations, serving federal, state, local, defense, intelligence, and private sectors.

Average Trading Volume: 1,418,120

Technical Sentiment Signal: Buy

Current Market Cap: $4.75B

Find detailed analytics on CLBT stock on TipRanks’ Stock Analysis page.